Effect of device design on the aerosolization of a carrier-based dry powder inhaler - A case study on aerolizer® foradile®

AAPS Journal

Volumn 15, Issue 2, 2013, Pages 511-522

  Zhou, Qi Tony ^a   Tong, Zhenbo ^b   Tang, Patricia ^a   Citterio, Mauro ^c   Yang, Runyu ^b   Chan, Hak Kim ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c R and D and Industrialization Plastiape SpA   (Italy)

Author keywords

aerosolization; computational fluid dynamics; device design; discrete element method; dry powder inhalers

Indexed keywords

DRUG CARRIER; FORMOTEROL FUMARATE;

AEROSOL; AIR INLET SIZE; AIRFLOW; ARTICLE; CASE STUDY; DRUG DETERMINATION; DRUG FORMULATION; DRY POWDER INHALER; FLOW RATE; PARTICLE SIZE; POWDER; SIMULATION;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-2 RECEPTOR AGONISTS; AEROSOLS; BRONCHODILATOR AGENTS; CHEMISTRY, PHARMACEUTICAL; COMPUTER SIMULATION; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRY POWDER INHALERS; EQUIPMENT DESIGN; ETHANOLAMINES; PARTICLE SIZE; POWDERS; RHEOLOGY; TECHNOLOGY, PHARMACEUTICAL;

EID: 84877024842     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/s12248-013-9458-6     Document Type: Article

References (22)

1. Chan HK. Dry powder aerosol delivery systems: Current and future research directions. J Aerosol Med Depos Clearance Eff Lung. 2006;19(1):21-7.
2. Zhou Q, Morton DAV. Drug-lactose binding aspects in adhesive mixtures: Controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces. Adv Drug Deliv Rev. 2012;64(3):275-84.
3. De Boer AH, Chan HK, Price R. A critical view on lactose-based drug formulation and device studies for dry powder inhalation: Which are relevant and what interactions to expect? Adv Drug Deliv Rev. 2012;64(3):257-74.
4. Voss A, Finlay WH. Deagglomeration of dry powder pharmaceutical aerosols. Int J Pharm. 2002;248(1-2):39-50.
5. Coates MS, Fletcher DF, Chan HK, Raper JA. Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 1: grid structure and mouthpiece length. J Pharm Sci. 2004;93(11):2863-76.
6. Coates MS, Chan HK, Fletcher DF, Raper JA. Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 2: Air inlet size. J Pharm Sci. 2006;95(6):1382-92.
7. Coates MS, Chan HK, Fletcher DF, Chiou H. Influence of mouthpiece geometry on the aerosol delivery performance of a dry powder inhaler. Pharm Res. 2007;24(8):1450-6.
8. Donovan MJ, Kim SH, Raman V, Smyth HD. Dry powder inhaler device influence on carrier particle performance. J Pharm Sci. 2012;101(3):1097-107.
9. Shur J, Lee S, Adams W, Lionberger R, Tibbatts J, Price R. Effect of device design on the in vitro performance and comparability for capsule-based dry powder inhalers. AAPS J. 2012;14(4):667-676.
10. Tong ZB, Zheng B, Yang RY, Yu AB, Chan HK (2012). CFD-DEM investigation of the dispersion mechanisms in commercial dry powder inhalers. Powder Technol. 2012. doi: 10.1016/j.powtec.2012.07.012.
11. Young PM, Roberts D, Chiou H, Rae W, Chan HK, Traini D. Composite carriers improve the aerosolisation efficiency of drugs for respiratory delivery. J Aerosol Sci. 2008;39(1):82-93.
12. Asking L, Olsson B. Calibration at different flow rates of a multistage liquid impinger. Aerosol Sci Technol. 1997;27(1):39-49.
13. Chew NYK, Chan HK. In vitro aerosol performance and dose uniformity between the Foradile (R) Aerolizer (R) and the Oxis (R) Turbuhaler (R). J Aerosol Med Depos Clearance Eff Lung. 2001;14(4):495-501.
14. Kumon M, Kwok PCL, Adi H, Heng D, Chan HK. Can low-dose combination products for inhalation be formulated in single crystalline particles? Eur J Pharm Sci. 2010;40(1):16-24.
15. Zhu HP, Zhou ZY, Yang RY, Yu AB. Discrete particle simulation of particulate systems: Theoretical developments. Chem Eng Sci. 2007;62(13):3378-96.
16. Wang B, Xu DL, Chu KW, Yu AB. Numerical study of gas-solid flow in a cyclone separator. Appl Math Model. 2006;30(11):1326-42.
17. Launder BE, Reece GJ, Rodi W. Progress in development of a Reynolds-stress turbulence closure. J Fluid Mech. 1975;68:537-66.
18. Chu KW, Wang B, Yu AB, Vince A. CFD-DEM modelling of multiphase flow in dense medium cyclones. Powder Technol. 2009;193(3):235-47.
19. Coates MS, Chan HK, Fletcher DF, Raper JA. Influence of air flow on the performance of a dry powder inhaler using computational and experimental analyses. Pharm Res. 2005;22(9):1445-53.
20. Clark AR, Hollingworth AM. The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers - implications for In vitro testing. J Aerosol Med Depos Clearance Eff Lung. 1993;6(2):99-110.
21. Srichana T, Martin GP, Marriott C. Dry powder inhalers: The influence of device resistance and powder formulation on drug and lactose deposition in vitro. Eur J Pharm Sci. 1998;7(1):73-80.
22. Zhou QT, Armstrong B, Larson I, Stewart PJ, Morton DAV. Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders. Eur J Pharm Sci. 2010;40(5):412-21.